JPS6215194B2 - - Google Patents
Info
- Publication number
- JPS6215194B2 JPS6215194B2 JP16842383A JP16842383A JPS6215194B2 JP S6215194 B2 JPS6215194 B2 JP S6215194B2 JP 16842383 A JP16842383 A JP 16842383A JP 16842383 A JP16842383 A JP 16842383A JP S6215194 B2 JPS6215194 B2 JP S6215194B2
- Authority
- JP
- Japan
- Prior art keywords
- test tube
- physiologically active
- enzymes
- polystyrene
- immobilized
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000012360 testing method Methods 0.000 claims description 50
- 102000004190 Enzymes Human genes 0.000 claims description 23
- 108090000790 Enzymes Proteins 0.000 claims description 23
- 239000004793 Polystyrene Substances 0.000 claims description 23
- 229920002223 polystyrene Polymers 0.000 claims description 23
- 239000013543 active substance Substances 0.000 claims description 21
- 239000000427 antigen Substances 0.000 claims description 12
- 102000036639 antigens Human genes 0.000 claims description 12
- 108091007433 antigens Proteins 0.000 claims description 12
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 claims description 10
- 229910000077 silane Inorganic materials 0.000 claims description 10
- 239000003431 cross linking reagent Substances 0.000 claims description 9
- 229940088598 enzyme Drugs 0.000 description 22
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 16
- 238000006243 chemical reaction Methods 0.000 description 14
- 239000000243 solution Substances 0.000 description 13
- 238000005259 measurement Methods 0.000 description 11
- 235000012000 cholesterol Nutrition 0.000 description 8
- 229940107161 cholesterol Drugs 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 102000003992 Peroxidases Human genes 0.000 description 5
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 5
- 238000003018 immunoassay Methods 0.000 description 5
- 108040007629 peroxidase activity proteins Proteins 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 4
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N 4-aminoantipyrine Chemical compound CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000011088 calibration curve Methods 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 238000003127 radioimmunoassay Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- WYTZZXDRDKSJID-UHFFFAOYSA-N (3-aminopropyl)triethoxysilane Chemical compound CCO[Si](OCC)(OCC)CCCN WYTZZXDRDKSJID-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 108010015776 Glucose oxidase Proteins 0.000 description 3
- 239000004366 Glucose oxidase Substances 0.000 description 3
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 238000004040 coloring Methods 0.000 description 3
- 229940109239 creatinine Drugs 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 229940116332 glucose oxidase Drugs 0.000 description 3
- 235000019420 glucose oxidase Nutrition 0.000 description 3
- 230000003100 immobilizing effect Effects 0.000 description 3
- 238000000691 measurement method Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- 239000010703 silicon Substances 0.000 description 3
- 229910052710 silicon Inorganic materials 0.000 description 3
- UUEWCQRISZBELL-UHFFFAOYSA-N 3-trimethoxysilylpropane-1-thiol Chemical compound CO[Si](OC)(OC)CCCS UUEWCQRISZBELL-UHFFFAOYSA-N 0.000 description 2
- 108010089254 Cholesterol oxidase Proteins 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- 108010093096 Immobilized Enzymes Proteins 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 102000000019 Sterol Esterase Human genes 0.000 description 2
- 108010055297 Sterol Esterase Proteins 0.000 description 2
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 2
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 2
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- -1 polypropylene Polymers 0.000 description 2
- 239000005373 porous glass Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 229940116269 uric acid Drugs 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- WWMIMRADNBGDHP-UHFFFAOYSA-N 2-hydroxyhexanedial Chemical compound O=CC(O)CCCC=O WWMIMRADNBGDHP-UHFFFAOYSA-N 0.000 description 1
- IWTYTFSSTWXZFU-UHFFFAOYSA-N 3-chloroprop-1-enylbenzene Chemical compound ClCC=CC1=CC=CC=C1 IWTYTFSSTWXZFU-UHFFFAOYSA-N 0.000 description 1
- 108091006112 ATPases Proteins 0.000 description 1
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 101000950981 Bacillus subtilis (strain 168) Catabolic NAD-specific glutamate dehydrogenase RocG Proteins 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 1
- 102000016901 Glutamate dehydrogenase Human genes 0.000 description 1
- 102000057621 Glycerol kinases Human genes 0.000 description 1
- 108700016170 Glycerol kinases Proteins 0.000 description 1
- 102000005548 Hexokinase Human genes 0.000 description 1
- 108700040460 Hexokinases Proteins 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000003855 L-lactate dehydrogenase Human genes 0.000 description 1
- 108700023483 L-lactate dehydrogenases Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- LTEHZKTUGUOICL-UHFFFAOYSA-N N'-[3-(dimethoxymethylsilyl)butyl]ethane-1,2-diamine Chemical compound COC(OC)[SiH2]C(C)CCNCCN LTEHZKTUGUOICL-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 102000013009 Pyruvate Kinase Human genes 0.000 description 1
- 108020005115 Pyruvate Kinase Proteins 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 102000014384 Type C Phospholipases Human genes 0.000 description 1
- 108010079194 Type C Phospholipases Proteins 0.000 description 1
- 108010092464 Urate Oxidase Proteins 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 102000013529 alpha-Fetoproteins Human genes 0.000 description 1
- 108010026331 alpha-Fetoproteins Proteins 0.000 description 1
- 230000009435 amidation Effects 0.000 description 1
- 238000007112 amidation reaction Methods 0.000 description 1
- 238000005576 amination reaction Methods 0.000 description 1
- 229960000510 ammonia Drugs 0.000 description 1
- 229940088623 biologically active substance Drugs 0.000 description 1
- HRQGCQVOJVTVLU-UHFFFAOYSA-N bis(chloromethyl) ether Chemical compound ClCOCCl HRQGCQVOJVTVLU-UHFFFAOYSA-N 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 150000001840 cholesterol esters Chemical class 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 108010029444 creatinine deiminase Proteins 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000007824 enzymatic assay Methods 0.000 description 1
- 230000020764 fibrinolysis Effects 0.000 description 1
- 239000005337 ground glass Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229910000040 hydrogen fluoride Inorganic materials 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- PHQOGHDTIVQXHL-UHFFFAOYSA-N n'-(3-trimethoxysilylpropyl)ethane-1,2-diamine Chemical compound CO[Si](OC)(OC)CCCNCCN PHQOGHDTIVQXHL-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 239000000813 peptide hormone Substances 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920005990 polystyrene resin Polymers 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000004756 silanes Chemical class 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229940036555 thyroid hormone Drugs 0.000 description 1
- 239000005495 thyroid hormone Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
Landscapes
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Description
【発明の詳細な説明】
本発明は酵素、抗原、抗体などの生理活性物質
を有機シランと架橋剤とを用いてポリスチレン試
験管内壁に固定した臨床化学簡易検査器に関する
ものである。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a simple clinical chemistry test device in which physiologically active substances such as enzymes, antigens, and antibodies are fixed to the inner wall of a polystyrene test tube using an organic silane and a crosslinking agent.
従来、生理活性物質を有機シランと架橋剤とを
用いて多孔性ガラスに固定化する方法や多孔性ガ
ラスの代りに硅素を含有する無機性または有機性
担体(ガラス、シリカ、シリコンなど)を用いて
生理活性物質を固定化する方法も試みられるが、
これらは生理活性物質の反応表面積を拡げるため
に、たとえ硝酸、フツ化水素などの表面処理を施
したとしても、単位面積当りの固定化生理活性が
低すぎるため、産業上の利用に供するには満足す
べき結果は得られない。即ちシリコンチユーブお
よびガラス試験管等の内壁への生理活性物質の固
定化率は本発明のポリスチレン試験管内壁へのそ
れに対して10%以下にすぎないのである。なおナ
イロンチユーブはその構造中にペプチド結合を有
するのでアミノ化、アミド化、アルキル化などに
より酵素等の生理活性物質を効率的に固定化する
ことも可能である。しかし、ナイロンチユーブは
実用に供される可能性はあるものの、強度等から
実用化されていないのでナイロン試験管への生理
活性物質を固定化する応用は現在の所不可能であ
る。一方、ラジオイムノアツセイ及び酵素免疫測
定法を簡略化する試みとしてポリプロピレン及び
ポリスチレン試験管内壁に直接生理活性物質を吸
着して検査に使用する試みがなされている。(シ
ー・リービングらジヤーナル・オブ・イムノロジ
ー109巻834頁(1972)C.Living etal、J.
Immunology 109、834、′72及びイー・エング
ボールら、ジヤーナル・オブ・イムノロジー109
巻、129頁(1972)E.Engvall etal、J.
Immunology109、129、′72)この方法は試験管
内に生理活性物質を含むアルカリ性溶液を満た
し、一夜37℃で 置することにより試験管内壁に
生理活性物質を吸着せしめることを原理としてい
るが、吸着量が非常に少量であること、比較的簡
単に内壁から離脱しやすいことなどのため同一試
験管での繰返し測定は不可能であり、また超徴量
の測定方法以外には応用出来ないのである。 Conventionally, methods have been used in which physiologically active substances are immobilized on porous glass using organic silane and a crosslinking agent, or inorganic or organic carriers containing silicon (glass, silica, silicon, etc.) are used instead of porous glass. Methods of immobilizing physiologically active substances have also been attempted, but
Even if these are subjected to surface treatment with nitric acid, hydrogen fluoride, etc. to expand the reaction surface area of physiologically active substances, the immobilized physiological activity per unit area is too low for industrial use. No satisfactory results are obtained. That is, the immobilization rate of physiologically active substances on the inner walls of silicon tubes, glass test tubes, etc. is only 10% or less compared to that on the inner walls of polystyrene test tubes of the present invention. Since nylon tubes have peptide bonds in their structure, it is also possible to efficiently immobilize physiologically active substances such as enzymes by amination, amidation, alkylation, etc. However, although nylon tubes have the potential to be put to practical use, they have not been put to practical use due to their strength and other factors, so it is currently impossible to apply them to immobilize physiologically active substances on nylon test tubes. On the other hand, in an attempt to simplify radioimmunoassay and enzyme immunoassay, attempts have been made to adsorb physiologically active substances directly onto the inner walls of polypropylene and polystyrene test tubes for use in tests. (C.Living et al. Journal of Immunology 109 p. 834 (1972) C.Living etal, J.
Immunology 109 , 834, '72 and E. Engbor et al., Journal of Immunology 109.
Vol. 129 (1972) E. Engvall etal, J.
Immunology 109 , 129, '72) The principle of this method is to fill a test tube with an alkaline solution containing a physiologically active substance and leave it at 37°C overnight to allow the biologically active substance to adsorb to the inner wall of the test tube. Because the amount is extremely small and it is relatively easy to separate from the inner wall, repeated measurements in the same test tube are impossible, and it cannot be applied to any method other than measuring supercollection. .
一般に酵素及び抗原、抗体は高価なものであ
り、日常の簡易測定検査に使用する場合に使い捨
ててしまうのは経済性からみて重大な問題であ
る。 Enzymes, antigens, and antibodies are generally expensive, and it is a serious problem from an economic standpoint that they are thrown away when used for simple daily measurement tests.
そこで本発明者は酵素、抗原、抗体等の生理活
性物質をポリスチレン試験管内壁に固定化するこ
とを試みたのである。即ち、ポリスチレン試験管
に何らかの処理により直接酵素、抗原、抗体等の
生理活性物質を固定化することが出来れば診断用
酵素的測定法、ラジオイムノアツセイ法及び酵素
免疫測定法等に用いる簡易検査器が製作できるこ
とになるのである。 Therefore, the present inventor attempted to immobilize physiologically active substances such as enzymes, antigens, and antibodies on the inner wall of polystyrene test tubes. In other words, if physiologically active substances such as enzymes, antigens, and antibodies can be directly immobilized on polystyrene test tubes by some kind of treatment, they can be used as simple tests for diagnostic enzymatic assays, radioimmunoassays, enzyme immunoassays, etc. This means that utensils can be manufactured.
従来、ポリスチレン樹脂(パウダー状)への酵
素等の蛋白質の固定化方法としてはクロロメチル
スチレンからアミノポリスチレンを調製〔エム・
ジエー・ホーンとアール・エー・ローゼン、フエ
ブスレター36巻、285頁(1973)、M.J.Horn&R.
A.Laursen、FEBS letters、36、285(′73)〕
し、これに酵素等の蛋白質を固定化する方法が知
られている。 Conventionally, as a method for immobilizing proteins such as enzymes on polystyrene resin (powder form), aminopolystyrene was prepared from chloromethylstyrene [M.
J.H. Horn and R.A. Rosen, Huebsletter vol. 36, p. 285 (1973), MJHorn & R.
A. Laursen, FEBS letters, 36 , 285 ('73)]
However, a method is known in which proteins such as enzymes are immobilized thereon.
しかしながらこの方法をポリスチレン試験管へ
の固定化に応用しようとしてもポリスチレン試験
管にはポリマー以外に添加物が存在するため使用
するクロロメチルエーテル、ジオキサン等の溶剤
により膨化溶解等の現象がみられて、生理活性物
質が固定化されることはないのである。 However, even when trying to apply this method to immobilization in polystyrene test tubes, phenomena such as swelling and dissolution were observed due to the solvents used, such as chloromethyl ether and dioxane, as polystyrene test tubes contain additives in addition to polymers. , physiologically active substances are not immobilized.
そこで本発明者は鋭意検討を重ねた結果、ポリ
スチレン試験管内壁に生理活性物質を固定化する
ために、有機シランを介在させ、架橋剤によつて
固定化することに成功したのである。 As a result of extensive research, the present inventors succeeded in immobilizing a physiologically active substance on the inner wall of a polystyrene test tube by interposing an organic silane and using a crosslinking agent.
詳細には、まず始めにポリスチレン試験管にγ
−アミノプロピルトリエトキシシラン等の有機シ
ランの原液を数滴々下して、試験管内壁をまんべ
んなくコーテイングして空気中に約1時間放置し
た後、脱イオン水にて洗浄するのである。この操
作によりポリスチレン試験管はすりガラス様の白
濁を呈するが、表面は比較的平滑であり、膨化も
少ない。こうして得られたポリスチレン試験管に
架橋剤として0.2〜1%グルタルアルデヒド水溶
液を加え、4℃で1〜2時間反応させる。この場
合、ポリスチレンと有機シランとは一般に直接反
応を行わないと考えられているので、上記反応の
結果、ポリスチレンと有機シランとが直接共有結
合を生じているかどうか明らかではない。 In detail, first, γ was placed in a polystyrene test tube.
- A few drops of a stock solution of an organic silane such as aminopropyltriethoxysilane are applied to evenly coat the inner wall of the test tube, and the test tube is left in the air for about an hour, and then washed with deionized water. As a result of this operation, the polystyrene test tube becomes cloudy like ground glass, but the surface is relatively smooth and there is little swelling. A 0.2 to 1% aqueous glutaraldehyde solution is added as a crosslinking agent to the polystyrene test tube obtained in this way, and the mixture is reacted at 4°C for 1 to 2 hours. In this case, since it is generally thought that polystyrene and organic silane do not react directly, it is not clear whether a direct covalent bond is formed between polystyrene and organic silane as a result of the above reaction.
水洗後、酵素、抗原、抗体などの生理活性物質
溶液を加えて室温で2時間または4℃で一夜ゆる
やかに試験管を回転させながら反応させる。反応
終了後、反応に使用した緩衝液及び0.5MNaClで
充分洗浄したあと、0.2Mエタノールアミン緩衝
液(PH8.0)でよく洗浄し、未反応基をアミノ基
でブロツクする。なお生理活性物質溶液の濃度範
囲は広く0.01mg/ml程度でも充分固定化が可能で
ある。 After washing with water, a solution of physiologically active substances such as enzymes, antigens, and antibodies is added and allowed to react at room temperature for 2 hours or overnight at 4° C. while gently rotating the test tube. After the reaction is completed, the sample is thoroughly washed with the buffer used in the reaction and 0.5M NaCl, and then thoroughly washed with 0.2M ethanolamine buffer (PH8.0), and unreacted groups are blocked with amino groups. Note that the concentration range of the physiologically active substance solution is wide, and sufficient immobilization is possible even at about 0.01 mg/ml.
ただし有機シランとしてγ−メルカプトプロピ
ルトリメトキシシランで処置したポリスチレン試
験管は反応基のSH基をS−S結合とするためグ
ルタルアルデヒドの代りに1.5mMの2・2−ジ
ピリジルサルフアイド(2・2−
dipyridylsulfide)で処理し、洗浄したのち、生
理活性物質溶液を加えて固定化しなければならな
い。 However, in polystyrene test tubes treated with γ-mercaptopropyltrimethoxysilane as the organic silane, 1.5mM of 2,2-dipyridyl sulfide (2,2 −
After treatment with dipyridylsulfide and washing, a physiologically active substance solution must be added for immobilization.
本固定化に使用する有機シランとしてはγ−ア
ミノプロピルトリエトキシシランおよびγ−メル
カプトプロピルトリメトキシシランの他にN−β
−アミノエチル−γ−アミノプロピルトリメトキ
シシラン、N−β−アミノエチル−α−メチル−
γ−アミノプロピルジメトキシメチルシラン、N
−ビス−β−ヒドロキシエチル−γ−アミノプロ
ピルトリエトキシシラン等があげられる。 In addition to γ-aminopropyltriethoxysilane and γ-mercaptopropyltrimethoxysilane, the organic silanes used for this immobilization include N-β
-aminoethyl-γ-aminopropyltrimethoxysilane, N-β-aminoethyl-α-methyl-
γ-Aminopropyldimethoxymethylsilane, N
-bis-β-hydroxyethyl-γ-aminopropyltriethoxysilane and the like.
又架橋剤としては上記グルタルアルデヒド、
2・2−ジビリジルサルフアイドの他に酵素等の
架橋剤として一般に使用されているヒドロキシア
ジプアルデヒド、種々のイソシアネート誘導体等
が用いられる。 In addition, as a crosslinking agent, the above-mentioned glutaraldehyde,
In addition to 2,2-dibyridyl sulfide, hydroxyadipaldehyde, which is commonly used as a crosslinking agent for enzymes, various isocyanate derivatives, and the like can be used.
この固定化方法によつて得られる生理活性物質
固定化物は、ポリスチレン試験管内壁上に有機シ
ラン及び架橋剤を介して生理活性物質が固定化さ
れている。そしてこの固定化物はすぐれた臨床化
学簡易検査器となる。 In the physiologically active substance immobilized product obtained by this immobilization method, the physiologically active substance is immobilized on the inner wall of a polystyrene test tube via an organic silane and a crosslinking agent. This immobilized product becomes an excellent simple clinical chemistry test device.
本発明の臨床化学簡易検査器を診断用酵素的測
定法に適用する場合には次の各検査項目が挙げら
れる。即ち、血糖、尿素窒素、尿酸、クレアチニ
ン、アンモニア、コレステロール、中性脂質、燐
脂質、GOT、GPT、凝固線溶検査、補体結合反
応などである。 When the simple clinical chemistry test device of the present invention is applied to a diagnostic enzymatic measurement method, the following test items can be mentioned. That is, blood sugar, urea nitrogen, uric acid, creatinine, ammonia, cholesterol, neutral lipids, phospholipids, GOT, GPT, coagulation fibrinolysis test, complement fixation reaction, etc.
また、ラジオイムノアツセイ、および酵素免疫
測定法への適用例としてはIgG、IgA、IgM、
IgD、IgE、α−フエトプロテイン、Hb抗原、
CRP、インシユリン、各種ステロイドホルモ
ン、甲状腺ホルモン、各種ペプタイドホルモン等
の定量および薬物中毒の検査などがあげられる。 In addition, examples of application to radioimmunoassay and enzyme immunoassay include IgG, IgA, IgM,
IgD, IgE, α-fetoprotein, Hb antigen,
Examples include quantitative measurements of CRP, insulin, various steroid hormones, thyroid hormones, and various peptide hormones, as well as tests for drug toxicity.
本発明における生理活性物質としての酵素、抗
原、抗体の例としては上記の臨床用測定項目に用
いられる酵素はほとんどすべてポリスチレン試験
管に固定化されるが、特に例示すれば次の如きも
のである。 As examples of enzymes, antigens, and antibodies as physiologically active substances in the present invention, almost all enzymes used in the above clinical measurement items are immobilized on polystyrene test tubes, but the following are particularly exemplified. .
即ち酵素としてはブドウ糖定量用としてのグル
コースオキシターゼ、パーオキシダーゼ、カタラ
ーゼ、ヘキソキナーゼ、G−6−Pデヒドロゲナ
ーゼ等、尿素窒素定量用としてのウレアーゼ、尿
酸定量用としてのウリカーゼ、アンモニア定量用
としてのグルタメートデヒドロゲナーゼ、クレア
チニン定量用としてのクレアチニンアミドヒドロ
ラーゼ、クレアチニンデイミナーゼ、コレステロ
ール定量用としてのコレステロールエステルヒド
ロラーゼ、コレステロールオキシダーゼ、トリグ
リセライド定量用としてのリパーゼ、グリセロー
ルキナーゼ、パイルベートキナーゼ、ラクテート
デヒドロゲナーゼ、燐脂質定量用としてのホスホ
リパーゼC、アルカリホスフアターゼ、ATPase
等である。しかしながら上記酵素に限定されず、
あるゆる診断用酵素が適応されうる。 That is, the enzymes include glucose oxidase, peroxidase, catalase, hexokinase, G-6-P dehydrogenase, etc. for glucose determination, urease for urea nitrogen determination, uricase for uric acid determination, glutamate dehydrogenase for ammonia determination, Creatinine amide hydrolase for creatinine determination, creatinine deiminase, cholesterol ester hydrolase for cholesterol determination, cholesterol oxidase, lipase for triglyceride determination, glycerol kinase, pyruvate kinase, lactate dehydrogenase, phospholipase C for phospholipid determination , alkaline phosphatase, ATPase
etc. However, it is not limited to the above enzymes,
Any diagnostic enzyme can be applied.
そして抗原、抗体としては各種免疫グロブリ
ン、ホルモン、蛋白質等の抗原及びそれに対する
抗体はすべて可能である。 As antigens and antibodies, all antigens such as various immunoglobulins, hormones, and proteins, and antibodies against these antigens can be used.
以上の如く、本発明においてポリスチレン試験
管に有機シランと架橋剤を介して酵素、抗原、抗
体などの生理活性物質を固定化した臨床化学簡易
検査器を診断用酵素的測定法、ラジオイムノアツ
セイおよび酵素免疫測定法などの臨床化学簡易検
査方法へ利用する場合の特徴には、(1)固定化効率
がよい、(2)定量性がよい、(3)簡単に測定できる。
(緩衝液または反応呈色液を添加すれば簡単にど
こでも測定できる。)(4)一本の試験管でくり返し
長期間の測定が可能である。(例えば酵素的測定
法では1〜2ケ月は1本の試験管でくり返し測定
できる。)(5)簡単に試験管に固定化出来、そのま
ま測定に使用できるので経済性がある、等の効果
があげられる。 As described above, in the present invention, a simple clinical chemistry test device in which physiologically active substances such as enzymes, antigens, and antibodies are immobilized on a polystyrene test tube via an organic silane and a crosslinking agent can be used for diagnostic enzymatic measurement methods, radioimmunoassays, etc. The characteristics when used in clinical chemistry simple test methods such as enzyme immunoassay and enzyme immunoassay are (1) good immobilization efficiency, (2) good quantitative performance, and (3) easy measurement.
(Measurements can be easily made anywhere by adding a buffer solution or reaction coloring solution.) (4) Repeated long-term measurements are possible with a single test tube. (For example, in the enzymatic measurement method, measurements can be repeated in one test tube for 1 to 2 months.) (5) It can be easily immobilized in a test tube and used for measurements as is, making it economical. can give.
次に本発明の実施例について示す。 Next, examples of the present invention will be described.
実施例 1
ポリスチレン試験管(10mm×50mmまたは15mm×
100mm)にγ−アミノプロピルトリエトキシシラ
ン原液数滴を滴下し、所定の高さ(10〜50mm)ま
で試験管内壁をまんべんなくコーテイングし、空
気中に約1時間放置し、水洗後1%グルタルアル
デヒド(PH7.4)を5ml加え氷冷下で、1時間反
応させ洗浄後グルコースオキシダーゼ(15EV/
ml)−パーオキシダーゼ(50V/ml)(いずれもシ
グマ製タイプ)(PH7.4)を0.5ml加え室温で1
〜2時間試験管内を回転させ両酵素を試験管内壁
に均一に固定化する。固定化後0.5MNaClで洗浄
し、未固定化酵素を除去したのち、0.2Mエタノ
ールアミン(PH8.0)で充分洗浄し(サーモミキ
サー使用)未反応基をアミノ基でブロツクする。
本固定化酵素のうちグルコースオキシダーゼの固
定化率は22%、パーオキシダーゼの固定化率は25
%である。(蛋白量として)
参考例 1
実施例1に準じて得られた固定化酵素をコーテ
イングしたポリスチレン試験管に0.6mM4−アミ
ノアンチピリン、10mMフエノール、50mMリン
酸カリ(PH7.4)からなる呈色液1.0ml、および血
清(人)10〜20μを加えて室温で反応を開始
し、10分経過後、試験管から反応液を取り出し、
比色計で(500nm)測定する。なお血清中のブ
ドウ糖量はあらかじめブドウ糖水溶液の標準検量
線を求めておき、一方、反応により得られた供給
血清の測定値を検量線に対応させて求める。本検
査器は室温に放置して定色液添加や洗滌をくりか
えしても、少なくとも1ケ月連続使用可能であ
る。Example 1 Polystyrene test tube (10 mm x 50 mm or 15 mm x
100 mm), drop several drops of γ-aminopropyltriethoxysilane stock solution, coat the inner wall of the test tube evenly to a specified height (10 to 50 mm), leave it in the air for about 1 hour, and after washing with water, coat it with 1% glutaraldehyde. Add 5ml of (PH7.4) and react for 1 hour under ice cooling. After washing, glucose oxidase (15EV/
ml) - Add 0.5 ml of peroxidase (50V/ml) (both types manufactured by Sigma) (PH7.4) and mix at room temperature.
Rotate the test tube for ~2 hours to uniformly immobilize both enzymes on the inner wall of the test tube. After immobilization, wash with 0.5M NaCl to remove unimmobilized enzyme, and then wash thoroughly with 0.2M ethanolamine (PH8.0) (using a thermomixer) to block unreacted groups with amino groups.
Among these immobilized enzymes, the immobilization rate of glucose oxidase is 22%, and the immobilization rate of peroxidase is 25%.
%. (As protein amount) Reference Example 1 A coloring solution consisting of 0.6mM 4-aminoantipyrine, 10mM phenol, and 50mM potassium phosphate (PH7.4) was placed in a polystyrene test tube coated with the immobilized enzyme obtained according to Example 1. Add 1.0ml and 10-20μ of serum (human) to start the reaction at room temperature, and after 10 minutes, remove the reaction solution from the test tube.
Measure with a colorimeter (500 nm). Note that the amount of glucose in the serum is determined in advance by determining a standard calibration curve of an aqueous glucose solution, and on the other hand, the measured value of the supplied serum obtained by the reaction is determined by making it correspond to the calibration curve. This tester can be used continuously for at least one month even if left at room temperature and repeated addition of color fixing solution and washing.
なお、測定において、試料を添加して数秒で肉
眼的に明らかな発色を呈するので30秒〜1分間放
置すれば充分測定可能であるが、エンドポイント
で測る場合には約10分間は放置した方がよい。な
お又この操作上の特色としては反応停止操作を必
要としない点にある。 In addition, during measurement, a color develops that is visible to the naked eye within a few seconds after adding the sample, so it is sufficient to measure if the sample is left for 30 seconds to 1 minute, but when measuring at the end point, it is recommended to leave it for about 10 minutes. Good. Furthermore, a feature of this operation is that no reaction termination operation is required.
参考例 2
実施例1に準じてコレステロールオキシダー
ゼ、パーオキシダーゼの混液をポリスチレン試験
管の内壁に固定化したものに、参考例1で使用し
た反応液(4アミノアンチピリン−フエノール−
リン酸カリ(PH7.4)にトライトンX−100(ロー
ムアンドハース社製品名)を最終濃度で0.1%に
なるように加え、これに試料(血清)20μを添
加して反応を開始し、15分経過後試験管から反応
液を取り出し、比色計にて500nmのODを測定
し、あらかじめ求めておいたコレステロール検量
線より遊離コレステロール量を測定する。なお総
コレステロール量を測定する場合には別のポリス
チレン試験管(10×50mm)にコレステロールエス
テルヒドロラーゼを固定化しておき、この試験管
に血清20μと0.1%トライトンX−100含有
0.1Mリン酸緩衝液(PH7.0)0.5mlを加え、前以つ
てコレステロールエステルを水解しておき(37℃
で20分間反応)、これを遊離コレステロール測定
用試験管に移しかえ上記呈色反応液を加えて前記
と同様に比色測定し、コレステロール検量線より
総コレステロール量を求める。Reference Example 2 A mixture of cholesterol oxidase and peroxidase was immobilized on the inner wall of a polystyrene test tube according to Example 1, and the reaction solution used in Reference Example 1 (4-aminoantipyrine-phenol-
Add Triton After a few minutes have elapsed, the reaction solution is taken out from the test tube, the OD at 500 nm is measured using a colorimeter, and the amount of free cholesterol is measured using a cholesterol calibration curve determined in advance. When measuring the total cholesterol amount, cholesterol ester hydrolase is immobilized in another polystyrene test tube (10 x 50 mm), and this test tube contains 20μ of serum and 0.1% Triton X-100.
Add 0.5 ml of 0.1M phosphate buffer (PH7.0) to previously hydrolyze cholesterol ester (at 37°C).
(react for 20 minutes), transfer this to a test tube for measuring free cholesterol, add the above coloring reaction solution, perform colorimetric measurement in the same manner as above, and determine the total cholesterol amount from the cholesterol calibration curve.
参考例 3
実施例1に準じてポリスチレン試験管に抗ヒト
IgG抗血清を固定化したものに、パーオキシダー
ゼを固定化したIgG(S.Avrameas&B.Guilbert.
Biochimie、54、837、(′72)の方法で調製)と
IgGを含む試料(10000倍希釈の血清)10〜50μ
をリン酸緩衝液(PH7.4)と共に加え競走的に
抗体を結合させ、上清を捨て充分洗浄したのち、
基質である過酸化水素を加え参考例1で用いた反
応液(4−アミノアンチピリンフエノール緩衝
液)で反応後比色し(500nm)、得られるOD値
をあらかじめ求めておいた標準曲線と対応させ、
試料中のIgG量を求める。Reference Example 3 According to Example 1, anti-human was added to a polystyrene test tube.
IgG antiserum was immobilized with peroxidase immobilized IgG (S. Avrameas & B. Guilbert.
Biochimie, 54, 837, ('72)) and
Sample containing IgG (serum diluted 10,000 times) 10-50μ
was added together with phosphate buffer (PH7.4) to competitively bind the antibody, and the supernatant was discarded and thoroughly washed.
After adding hydrogen peroxide as a substrate and reacting with the reaction solution (4-aminoantipyrine phenol buffer) used in Reference Example 1, perform color comparison (500 nm), and compare the obtained OD value with the standard curve determined in advance. ,
Determine the amount of IgG in the sample.
Claims (1)
架橋剤を介して酵素、抗原、抗体などの生理活性
物質を化学結合させてなる臨床化学簡易検査器。1. A simple clinical chemistry test device in which physiologically active substances such as enzymes, antigens, and antibodies are chemically bonded to the inner wall of a polystyrene test tube via an organic silane and a crosslinking agent.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16842383A JPS59130178A (en) | 1983-09-14 | 1983-09-14 | Simple test device for clinical chemistry |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16842383A JPS59130178A (en) | 1983-09-14 | 1983-09-14 | Simple test device for clinical chemistry |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP10315176A Division JPS5921596B2 (en) | 1976-08-31 | 1976-08-31 | Physiologically active substance immobilization method and clinical chemistry simple test device |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS59130178A JPS59130178A (en) | 1984-07-26 |
| JPS6215194B2 true JPS6215194B2 (en) | 1987-04-06 |
Family
ID=15867844
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP16842383A Granted JPS59130178A (en) | 1983-09-14 | 1983-09-14 | Simple test device for clinical chemistry |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS59130178A (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4728140B2 (en) * | 2005-02-21 | 2011-07-20 | 国立大学法人九州大学 | Protein immobilization method |
-
1983
- 1983-09-14 JP JP16842383A patent/JPS59130178A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS59130178A (en) | 1984-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5955335A (en) | Biomaterial immobilization on an Si3 N4 surface containing Si-NH2 groups with a heterobifunctional cross-linking agent | |
| FR2590674A1 (en) | NEW DIAGNOSTIC REAGENTS | |
| EP0408578A1 (en) | Enzymatically amplified piezoelectric specific binding assay. | |
| FR2521303A1 (en) | METHOD FOR THE IMMUNOLOGICAL DETERMINATION OF IMMUNOGLOBULIN TYPE ANTIBODIES OF SPECIFIC CLASS | |
| US4477576A (en) | Antigen assay method and kit | |
| US5314830A (en) | Immobilized hydrophobically-modified antibodies | |
| JPS6215194B2 (en) | ||
| JPH01209370A (en) | Method and apparatus for measuring immunologically active substance | |
| JPS5921596B2 (en) | Physiologically active substance immobilization method and clinical chemistry simple test device | |
| US4510240A (en) | Homogeneous enzyme immunoassay with heating step after incubation, THERESIA | |
| JPS628055A (en) | Enzymatic immunoassay | |
| MXPA97002515A (en) | Biosensor with biomaterial covalentely fixed a signal surface act | |
| JPS61241665A (en) | Stabilized sold phase reagent | |
| JPH0587814A (en) | Method and medicine for rheumatism diagnosis and determination method for agalactosill igg | |
| JPH0236353A (en) | Immunoassay | |
| US4250253A (en) | Composition adapted for the determination of tri-iodo thyronine and diagnosis method employing same | |
| JPH06289020A (en) | Method for measuring alveolar bone-derived protein | |
| JPH04194753A (en) | Antigen for measuring anti-ssa/ro or ssb/la antibody, manufacture thereof and measuring method for anti-ssa/ ro or ssb/la antibody | |
| JPS58144747A (en) | Highly sensitive measurement of s-100 protein | |
| JP2816767B2 (en) | Method for producing immobilized antibody | |
| JPH01102352A (en) | Biosensor | |
| JPS63159759A (en) | Enzyme immunoassay | |
| JPH07122622B2 (en) | Immunosensor | |
| JPS62159048A (en) | Method for measuring bioactivity of protein s | |
| JPH10506788A (en) | How to immobilize biological material on a substrate |